Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment BusinessWire
Market data is delayed by at least 15 minutes.
    Latest Story Top Stories on JNJ
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: DecisionPoint Systems, Inc. (NYSE American - DPSI), AdTheorent Holding Company, Inc. (Nasdaq - ADTH), Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical, Inc. (Nasdaq - SWAV)
    12:22p ET May 6 '24 GlobeNewswire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: DecisionPoint Systems, Inc. (NYSE American - DPSI), AdTheorent Holding Company, Inc. (Nasdaq - ADTH), Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical, Inc. (Nasdaq - SWAV)GlobeNewswireMay 06, 2024

    BALA CYNWYD, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

    DecisionPoint Systems, Inc. (NYSE American - DPSI)

    Under the terms of the agreement, DecisionPoint will be acquired by an affiliate of Barcoding Holdings, LLC ("Barcoding"), a portfolio company of Graham Partners, in an all-cash transaction. Under the terms of the agreement, DecisionPoint stockholders will receive $10.22 per share in cash for each share they hold. The investigation concerns whether the DecisionPoint Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration offers fair value to the Company's shareholders.

    Additional information can be found at https://www.brodskysmith.com/cases/decisionpoint-systems-inc-nyse-american-dpsi/.

    AdTheorent Holding Company, Inc. (Nasdaq - ADTH)

    Under the terms of the agreement, AdTheorent will be acquired by Cadent, LLC ("Cadent"). Under the terms of the definitive merger agreement, the Company's common stockholders will receive cash consideration of $3.21 per share. The transaction represents an equity value for the Company of approximately $324 million. The investigation concerns whether the AdTheorent Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration offers fair value to the Company's shareholders. For example, the deal consideration is below the 52-week high of $3.98 for the Company's shares.

    Additional information can be found at https://www.brodskysmith.com/cases/adtheorent-holding-company-inc-nasdaq-adth/.

    Macatawa Bank Corporation (Nasdaq - MCBC)

    Under the terms of the agreement, Macatawa will be acquired by Wintrust Financial Corporation ("Wintrust") (Nasdaq - WTFC) Each share of Macatawa common stock outstanding will be converted into the right to receive merger consideration paid in shares of Wintrust common stock based on Wintrust's average trading price at closing determined in accordance with the merger agreement. The aggregate purchase price to Macatawa shareholders is currently estimated to be approximately $510.3 million, or $14.85 per share. The investigation concerns whether the Macatawa Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the offer from Wintrust provides fair value to the Company's shareholders.

    Additional information can be found at https://www.brodskysmith.com/cases/macatawa-bank-corporation-nasdaq-mcbc/.

    Shockwave Medical, Inc. (Nasdaq - SWAV)

    Under the terms of the Merger Agreement, Shockwave will be acquired by Johnson & Johnson (NYSE - JNJ). Johnson & Johnson will acquire all outstanding shares of Shockwave common stock for $335.00 per share in cash, corresponding to an enterprise value of approximately $13.1 billion including cash acquired. The investigation concerns whether the Shockwave Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration offers fair value to the Company's shareholders.

    Additional information can be found at https://www.brodskysmith.com/cases/shockwave-medical-inc-nasdaq-swav/.

    Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

    COMTEX_451967297/2010/2024-05-06T12:22:10

    BALA CYNWYD, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

    DecisionPoint Systems, Inc. (NYSE American - DPSI)

    Under the terms of the agreement, DecisionPoint will be acquired by an affiliate of Barcoding Holdings, LLC ("Barcoding"), a portfolio company of Graham Partners, in an all-cash transaction. Under the terms of the agreement, DecisionPoint stockholders will receive $10.22 per share in cash for each share they hold. The investigation concerns whether the DecisionPoint Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration offers fair value to the Company's shareholders.

    Additional information can be found at https://www.brodskysmith.com/cases/decisionpoint-systems-inc-nyse-american-dpsi/.

    AdTheorent Holding Company, Inc. (Nasdaq - ADTH)

    Under the terms of the agreement, AdTheorent will be acquired by Cadent, LLC ("Cadent"). Under the terms of the definitive merger agreement, the Company's common stockholders will receive cash consideration of $3.21 per share. The transaction represents an equity value for the Company of approximately $324 million. The investigation concerns whether the AdTheorent Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration offers fair value to the Company's shareholders. For example, the deal consideration is below the 52-week high of $3.98 for the Company's shares.

    Additional information can be found at https://www.brodskysmith.com/cases/adtheorent-holding-company-inc-nasdaq-adth/.

    Macatawa Bank Corporation (Nasdaq - MCBC)

    Under the terms of the agreement, Macatawa will be acquired by Wintrust Financial Corporation ("Wintrust") (Nasdaq - WTFC) Each share of Macatawa common stock outstanding will be converted into the right to receive merger consideration paid in shares of Wintrust common stock based on Wintrust's average trading price at closing determined in accordance with the merger agreement. The aggregate purchase price to Macatawa shareholders is currently estimated to be approximately $510.3 million, or $14.85 per share. The investigation concerns whether the Macatawa Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the offer from Wintrust provides fair value to the Company's shareholders.

    Additional information can be found at https://www.brodskysmith.com/cases/macatawa-bank-corporation-nasdaq-mcbc/.

    Shockwave Medical, Inc. (Nasdaq - SWAV)

    Under the terms of the Merger Agreement, Shockwave will be acquired by Johnson & Johnson (NYSE - JNJ). Johnson & Johnson will acquire all outstanding shares of Shockwave common stock for $335.00 per share in cash, corresponding to an enterprise value of approximately $13.1 billion including cash acquired. The investigation concerns whether the Shockwave Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration offers fair value to the Company's shareholders.

    Additional information can be found at https://www.brodskysmith.com/cases/shockwave-medical-inc-nasdaq-swav/.

    Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

    COMTEX_451967297/2010/2024-05-06T12:22:10

    Kenvue Announces Pricing of Secondary Offering
    7:13p ET May 14 '24 BusinessWire
    Kenvue Announces Launch of Secondary Offering
    6:46a ET May 13 '24 BusinessWire
    Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expe...
    12:16p ET May 9 '24 PR Newswire Europe
    Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expe...
    12:15p ET May 9 '24 PR Newswire
    Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Glo...
    4:30p ET May 8 '24 BusinessWire
    Shockwave Medical Reports First Quarter 2024 Financial Results
    4:05p ET May 6 '24 GlobeNewswire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Follow...
    12:22p ET May 6 '24 GlobeNewswire
    Johnson & Johnson to Participate in the 2024 RBC Capital Markets Glob...
    6:06p ET April 8 '24 BusinessWire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Follow...
    12:48p ET April 8 '24 GlobeNewswire
    CARVYKTI(R) is the First and Only BCMA-Targeted Treatment Approved by...
    11:22p ET April 5 '24 PR Newswire

    Market data provided by News provided by